STAAR Surgical Company (STAA)
NASDAQ: STAA · IEX Real-Time Price · USD
46.77
+0.43 (0.93%)
At close: Apr 18, 2024, 4:00 PM
46.00
-0.77 (-1.65%)
After-hours: Apr 18, 2024, 4:26 PM EDT
STAAR Surgical Company Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for STAA stock have an average target of 46, with a low estimate of 33 and a high estimate of 57. The average target predicts a decrease of -1.65% from the current stock price of 46.77.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for STAA stock from 10 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 1 | 1 | 1 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 6 | 8 | 8 | 7 | 6 | 7 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 9 | 9 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho | Mizuho | Strong Buy Maintains $45 → $53 | Strong Buy | Maintains | $45 → $53 | +13.32% | Apr 11, 2024 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $32 → $46 | Hold | Maintains | $32 → $46 | -1.65% | Apr 8, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Apr 4, 2024 |
| Stifel | Stifel | Strong Buy Maintains $50 | Strong Buy | Maintains | $50 | +6.91% | Apr 1, 2024 |
| Stifel | Stifel | Hold → Strong Buy Upgrades $30 → $50 | Hold → Strong Buy | Upgrades | $30 → $50 | +6.91% | Mar 11, 2024 |
Financial Forecast
Revenue This Year
344.41M
from 322.42M
Increased by 6.82%
Revenue Next Year
401.24M
from 344.41M
Increased by 16.50%
EPS This Year
0.58
from 0.43
Increased by 35.74%
EPS Next Year
0.97
from 0.58
Increased by 66.19%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 356.8M | 424.8M | 530.9M | 645.0M | 752.2M |
| Avg | 344.4M | 401.2M | 481.9M | 617.3M | 722.8M |
| Low | 329.0M | 374.4M | 443.9M | 584.6M | 686.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 10.7% | 23.4% | 32.3% | 33.9% | 21.8% |
| Avg | 6.8% | 16.5% | 20.1% | 28.1% | 17.1% |
| Low | 2.0% | 8.7% | 10.6% | 21.3% | 11.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 0.78 | 1.24 | 1.58 | 2.27 | 2.68 |
| Avg | 0.58 | 0.97 | 1.39 | 2.15 | 2.51 |
| Low | 0.29 | 0.65 | 1.00 | 2.02 | 2.33 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 80.7% | 112.3% | 62.4% | 62.7% | 24.6% |
| Avg | 35.7% | 66.2% | 43.7% | 54.1% | 17.0% |
| Low | -31.6% | 10.8% | 3.0% | 44.8% | 8.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.